Medical Services related to Bonnie Ren Shiaw Wang MD

Hereditary Hemorrhagic Telangiectasia (HHT)

Hereditary Hemorrhagic Telangiectasia  (HHT) is a genetic disorder that affects about one in 5,000 people and commonly causes nosebleeds, with more frequent nosebleeds typically starting after about age 12.  Patients with HHT have a tendency to form blood vessels that are abnormal, fragile, and bleed more easily. Michigan Medicine has a multidisciplinary team of physicians to treat HHT, including specialists in otolaryngology (for nosebleeds), pulmonary diseases, interventional radiology, gastroenterology, neurosurgery, liver diseases, cardiology, heart failure, dermatology, radiation oncology, hematology-oncology and associated pediatric subspecialties.

Hereditary Hemorrhagic Telangiectasia (HHT) Treatment

There are many different specialists who treat patients with HHT. Many patients will eventually see two or more types of specialists, especially later in adulthood. Specialists who treat HHT include otolaryngologists (ear, nose & throat doctors), interventional radiologists (to treat AVMs), hematologists (to help manage anemia), and more.

Interstitial Lung Disease (ILD)

The University of Michigan Interstitial Lung Disease Program leads the field in accurate diagnostic methods, active scientific research and extensive clinical trials.

Lung Disease and Respiratory Care (Pulmonary)

Pulmonary Diseases and Critical Care physicians at the University of Michigan focus on pulmonary (lungs and breathing) disorders and critical illnesses (conditions such as shock, respiratory failure, and multiple organ failure). Our multidisciplinary teams treat the full scope of pulmonary issues including asthma, COPD and emphysema and cystic fibrosis.

Lymphangioleiomyomatosis (LAM) Clinic

The University of Michigan's dedicated lymphangioleiomyomastosis LAM Clinic is a LAM Foundation-approved clinic (the only one in the state of Michigan), which includes medical institutions with the expertise to deliver cutting-edge, coordinated, and multidisciplinary LAM care, and is also part of the LAM Foundation Clinical Research Network , performing cooperative research with other LAM clinics.

Pulmonary Critical Care

A division of Pulmonary and Critical Care Medicine at the University of Michigan, Critical Care Respiratory Support Services works with every Intensive Care Unit at the University of Michigan Health System, from Neurology to the Trauma Burn Unit with compassionate, licensed respiratory therapists providing the newest breathing treatments.

Pulmonary Fibrosis

At the University of Michigan, the Division of Pulmonary & Critical Care Medicine is a referral center, providing comprehensive care for people with pulmonary fibrosis. Our scientists and doctors are also using basic science to understand cells, molecules and pathways that lead to pulmonary fibrosis, in order to identify new therapies. Clinical trials evaluating these new therapies are in progress.

Women's Respiratory Clinic

The University of Michigan Women's Respiratory Clinic, part of the Department of Pulmonary & Critical Care Medicine, is dedicated to the care of female patients with respiratory disease, providing cutting-edge diagnostic, therapeutic, and surgical services, not only for lung disease but also for other conditions that may be involved, such as depression or anxiety, resulting from living with chronic lung disease.